CIK 0001783183
- Non-accelerated filer
- Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 824151574
- Phone
- +1 877-742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-06 | Narula Sanjeev Chief Financial & Bus. Officer | Shares withheld for taxes | −13,485 | $6.78 | $91K | 214,718 |
| 2026-01-02 | Narula Sanjeev Chief Financial & Bus. Officer | Grant or award | +82,715 | 226,715 | ||
| 2026-01-02 | Narula Sanjeev Chief Financial & Bus. Officer | Grant or award · Stock Option (Right to Buy) | +42,848 | 42,848 | ||
| 2025-10-06 | Narula Sanjeev Chief Financial & Bus. Officer | Grant or award | +144,000 | 144,000 | ||
| 2025-10-06 | Narula Sanjeev Chief Financial & Bus. Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 |
Page 1 of 1 · 5 trades